Hjem › Bløddelssarkom › Alabama › Birmingham
Bløddelssarkom kliniske forsøg i Birmingham, AL
5 studier for Bløddelssarkom søger deltagere på steder i og omkring Birmingham (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
RekruttererFase 2
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
DESTINY-PANTUMOUR04
RekruttererObservationsstudie
- Research Site, Birmingham
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
RekruttererFase 2
- Children's of Alabama, Birmingham
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Rekrutterer
- University of Alabama at Birmingham, Birmingham
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RekruttererFase 2
- Children's Hospital of Alabama/UAB, Birmingham
Bløddelssarkom forsøg i andre byer
- Houston, TX32 studier
- New York City, NY19 studier
- Boston, MA18 studier
- St. Louis, MO14 studier
- Columbus, OH13 studier
- Los Angeles, CA13 studier
- Washington, DC12 studier
- Memphis, TN11 studier
- Philadelphia, PA10 studier
- Rochester, MN9 studier
- Nashville, TN9 studier
- Aurora, CO9 studier
Andre studier i Birmingham
- Kræft (alle typer)30 studier
- Brystkræft24 studier
- Overvægt23 studier
- Ægstockræft23 studier
- Ikke-småcellet lungecancer22 studier
- Akut myeloid leukæmi21 studier
- Multipelt myelom18 studier
- KOL17 studier
- Kardiovaskulær sygdom17 studier
- Overvægt16 studier
- Livmoderslimhindekræft16 studier
- Type 2-diabetes16 studier
Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.